TRPV4-ATP-P2X受体信号通路对咳嗽高敏感性的作用及机制

批准号:
81770097
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
徐镶怀
依托单位:
学科分类:
H0114.呼吸系统疾病研究新技术与新方法
结题年份:
2021
批准年份:
2017
项目状态:
已结题
项目参与者:
余莉、秦颖、陈强、时翠芹、闻思婉、董冉、丁红梅、张梦茹
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
咳嗽高敏感性是难治性咳嗽的共同特征,与TRP家族密切相关,但拮抗TRPV1、TRPA1治疗咳嗽的证据不足。我们在动物研究中发现ATP参与咳嗽高敏感性,但与TRPV1无关;激活TRPV4可通过气道传入迷走神经纤维传导至结状神经节,可能影响咳嗽反射;多项研究提示ATP-P2X受体与TRPV4相关。故我们推测,活化TRPV4可导致气道上皮ATP释放,刺激咳嗽感受器上P2X受体,通过传入纤维传导至结状神经节诱发咳嗽。本研究拟建立柠檬酸吸入慢性咳嗽豚鼠模型,比较TRPV4激动剂、拮抗剂和P2X1-4, 7受体拮抗剂对咳嗽反应性的影响,检测神经节等组织P2X及TRPV4的mRNA和蛋白表达,采用在体和离体肺组织记录迷走神经单纤维放电活动的方法,观察豚鼠和TRPV4基因敲除小鼠对上述试剂的放电反应变化,证实TRPV4-ATP-P2X受体信号通路参与咳嗽高敏感性形成,并探讨其机制,为以此治疗咳嗽奠定基础。
英文摘要
Cough hypersensitivity, closely related to TRP family, is a common characteristic of refractory chronic cough. However, clinical evidences of TRPV1 and TRPA1 antagonism for treating cough are insufficient. In animal experiments, we found that ATP was involved in cough hypersensitivity but not related with TRPV1. However, activating TRPV4 may affect cough reflexes though conduction from airway vagal afferent nerves to nodose ganglions. Several studies have confirmed the relationship between ATP-P2X receptors and TRPV4. Thus, we speculated that activating TRPV4 could induce the release of ATP from airway epithelia, stimulate P2X receptors on cough receptors, and then induce cough though conduction from the afferent nerves to nodose ganglions. This study aims to establish a guinea pig model of citric acid induced chronic cough to compare the effects of TRPV4 agonist, TRPV4 antagonist, and P2X1-4, 7 receptor antagonists on cough sensitivity, to test mRNA and protein expressions of P2X and TRPV4 in ganglions, to observe the changes of discharge reactions of single pulmonary C-fiber in vitro and in vivo to the above-mentioned reagents in guinea pigs as well as TRPV4 knock-out mice, to confirm the involvement of TRPV4-ATP-P2X receptor signaling pathway in the formation of cough hypersensitivity, and to explore its mechanism, which can finally lay a foundation of treatments for chronic cough.
咳嗽高敏感性是难治性咳嗽的共同特征,与TRP家族密切相关,但拮抗TRPV1、TRPA1治疗咳嗽的证据不足。我们在动物研究中发现ATP参与咳嗽高敏感性,但与TRPV1无关;激活TRPV4可通过气道传入迷走神经纤维传导至结状神经节,可能影响咳嗽反射;多项研究提示ATP-P2X受体与TRPV4相关。故我们推测,活化TRPV4可导致气道上皮ATP释放,刺激咳嗽感受器上P2X受体,通过传入纤维传导至结状神经节诱发咳嗽。本研究建立了柠檬酸吸入慢性咳嗽豚鼠模型,比较了TRPV4激动剂、拮抗剂和P2X1-4, 7受体拮抗剂对咳嗽反应性的影响,检测了神经节等组织P2X及TRPV4的mRNA和蛋白表达,证实TRPV4-ATP-P2X受体信号通路参与咳嗽高敏感性形成,最终为以此治疗咳嗽奠定了基础。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Can acid exposure time replace the DeMeester score in the diagnosis of gastroesophageal reflux-induced cough?
酸暴露时间能否替代DeMeester评分诊断胃食管反流性咳嗽?
DOI:10.1177/20406223211056719
发表时间:2021
期刊:Therapeutic advances in chronic disease
影响因子:3.5
作者:Zhu Y;Tang J;Shi W;Wang S;Wu M;Lu L;Zhang M;Wen S;Shi C;Yu L;Xu X
通讯作者:Xu X
DOI:10.21037/jtd-2020-icc-001.
发表时间:2020
期刊:J Thorac Dis
影响因子:--
作者:Yu Li;Xu Xianghuai;Niu Shanshan
通讯作者:Niu Shanshan
Prediction of therapeutic efficacy of gabapentin by Hull Airway Reflux Questionnaire in chronic refractory cough
赫尔气道反流问卷预测加巴喷丁治疗慢性难治性咳嗽的疗效
DOI:10.21203/rs.3.rs-40955/v1
发表时间:2020-01
期刊:Therapeutic Advances in Chronic Disease
影响因子:3.5
作者:Zhang Mengru;Chen Qiang;Dong Ran;Yu Li;Ai Zisheng;Xu Xianghuai;Qiu Zhongmin
通讯作者:Qiu Zhongmin
DOI:10.1177/20406223211056719.
发表时间:2021
期刊:Therapeutic Advances in Chronic Disease
影响因子:3.5
作者:Yiqing Zhu;Junjun Tang;Wenbo Shi;Shengyuan Wang;Mingyan Wu;Lihua Lu;Mengru Zhang;Siwan Wen;Cuiqin Shi;Li Yu;Xianghuai Xu
通讯作者:Xianghuai Xu
DOI:10.21037/jtd.2019.09.62
发表时间:2019
期刊:Journal of Thoracic Disease
影响因子:2.5
作者:Wang Zhijing;Wang Miao;Wen Siwan;Yu Li;Xu Xianghuai
通讯作者:Xu Xianghuai
BTX-A通过瞬时受体电位离子通道介导对咳嗽高敏感性的作用及机制研究
- 批准号:82070102
- 项目类别:面上项目
- 资助金额:54万元
- 批准年份:2020
- 负责人:徐镶怀
- 依托单位:
ATP-P2X/P2Y受体-组胺对咳嗽高敏感性的作用及机制
- 批准号:81400071
- 项目类别:青年科学基金项目
- 资助金额:23.0万元
- 批准年份:2014
- 负责人:徐镶怀
- 依托单位:
国内基金
海外基金
